JP2010534063A5 - - Google Patents

Download PDF

Info

Publication number
JP2010534063A5
JP2010534063A5 JP2010517194A JP2010517194A JP2010534063A5 JP 2010534063 A5 JP2010534063 A5 JP 2010534063A5 JP 2010517194 A JP2010517194 A JP 2010517194A JP 2010517194 A JP2010517194 A JP 2010517194A JP 2010534063 A5 JP2010534063 A5 JP 2010534063A5
Authority
JP
Japan
Prior art keywords
lantibiotic
inactivated
degradation
hours
lantibiotics
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2010517194A
Other languages
English (en)
Japanese (ja)
Other versions
JP2010534063A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2008/070511 external-priority patent/WO2009058440A2/en
Publication of JP2010534063A publication Critical patent/JP2010534063A/ja
Publication of JP2010534063A5 publication Critical patent/JP2010534063A5/ja
Pending legal-status Critical Current

Links

JP2010517194A 2007-07-20 2008-07-18 ランチビオティックス及びこれらの使用 Pending JP2010534063A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US96137407P 2007-07-20 2007-07-20
PCT/US2008/070511 WO2009058440A2 (en) 2007-07-20 2008-07-18 Lantibiotics from bifidobacterium longum and uses thereof

Publications (2)

Publication Number Publication Date
JP2010534063A JP2010534063A (ja) 2010-11-04
JP2010534063A5 true JP2010534063A5 (enExample) 2011-09-01

Family

ID=40432080

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2010517194A Pending JP2010534063A (ja) 2007-07-20 2008-07-18 ランチビオティックス及びこれらの使用

Country Status (9)

Country Link
US (2) US7960505B2 (enExample)
EP (1) EP2176284B1 (enExample)
JP (1) JP2010534063A (enExample)
KR (1) KR20100043252A (enExample)
AU (1) AU2008319177B2 (enExample)
CA (1) CA2693307A1 (enExample)
DK (1) DK2176284T3 (enExample)
NZ (1) NZ582529A (enExample)
WO (1) WO2009058440A2 (enExample)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2010534063A (ja) * 2007-07-20 2010-11-04 リージェンツ オブ ザ ユニバーシティ オブ ミネソタ ランチビオティックス及びこれらの使用
MX350993B (es) * 2010-10-28 2017-09-27 Procter & Gamble Composiciones para el cuidado personal que comprenden una piritiona y un quelante de hierro.
EP2532232A1 (en) 2011-06-10 2012-12-12 InterMed Discovery GmbH Long chain glycolipids useful to avoid perishing or microbial contamination of materials
CA2865405C (en) 2012-02-27 2021-11-16 Oragenics, Inc. Replacement therapy for dental caries
US9573980B2 (en) 2013-03-15 2017-02-21 Spogen Biotech Inc. Fusion proteins and methods for stimulating plant growth, protecting plants from pathogens, and immobilizing Bacillus spores on plant roots
GB201409451D0 (en) 2014-05-28 2014-07-09 Ipabc Ltd Antimicrobial preparations, methods for preparing the same and uses thereof to combat microorganisms
EP3294867A1 (en) * 2015-05-12 2018-03-21 Novozymes A/S Bacillus licheniformis host cell with deleted lantibiotic gene(s)
CN106188253B (zh) * 2016-08-26 2020-08-18 上海交通大学 抗菌肽Lexapeptide及其制备方法和用途
US10738338B2 (en) 2016-10-18 2020-08-11 The Research Foundation for the State University Method and composition for biocatalytic protein-oligonucleotide conjugation and protein-oligonucleotide conjugate
CN108170988B (zh) * 2018-01-23 2021-01-01 成都希盟泰克科技发展有限公司 基于bim技术的隧道开挖三台阶七步方法
WO2020264076A1 (en) 2019-06-28 2020-12-30 The Procter & Gamble Company Light augmented treatment method
WO2021257953A1 (en) * 2020-06-19 2021-12-23 Healthy Cow Corporation Ready-to-use probiotic compositions and uses thereof
JP7570216B2 (ja) * 2020-11-30 2024-10-21 株式会社ヤクルト本社 ヒト腸内に長期定着する微生物のスクリーニング方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5260271A (en) * 1988-06-22 1993-11-09 Applied Microbiology, Inc. Nisin compositions for use as enhanced broad range bactericides
US6964760B2 (en) * 1997-06-10 2005-11-15 University Of Florida Research Foundation Antimicrobial polypeptide, nucleic acid, and methods of use
WO2001098516A2 (en) * 2000-06-19 2001-12-27 Regents Of The University Of Minnesota Siderophores-producing bifidobacteria thereby and uses thereof
CA2404356A1 (en) 2002-09-18 2004-03-18 Canadian Inovatech Inc. Gram-positive antibacterial composition and method for use
CA2508796A1 (en) 2002-12-10 2004-06-24 Biosynexus Incorporated Topical anti-infective formulations
US7326683B2 (en) * 2004-05-06 2008-02-05 Molichem Medicines, Inc. Treatment of membrane-associated diseases and disorders using lantibiotic containing compositions
EP1753445A4 (en) * 2004-05-06 2009-05-20 Molichem Medicines Inc TREATMENT OF EYE DISEASES AND EYE TREATMENTS WITH LANTIBIOTIC COMPOSITIONS
US20060024414A1 (en) * 2004-07-30 2006-02-02 Kraft Foods Holdings, Inc. Methods for preserving food products
JP2010534063A (ja) * 2007-07-20 2010-11-04 リージェンツ オブ ザ ユニバーシティ オブ ミネソタ ランチビオティックス及びこれらの使用

Similar Documents

Publication Publication Date Title
JP2010534063A5 (enExample)
Konings The cell membrane and the struggle for life of lactic acid bacteria
Iyapparaj et al. Optimization of bacteriocin production by Lactobacillus sp. MSU3IR against shrimp bacterial pathogens
JP3430853B2 (ja) 胃炎、胃潰瘍および十二指腸潰瘍の予防剤並びに治療剤
EP2176284B1 (en) Lantibiotics and uses thereof
JP2008545774A5 (enExample)
US12257284B2 (en) Lantibiotics, lantibiotic-producing bacteria, compositions and methods of production and use thereof
JP2009538614A5 (enExample)
Todorov et al. Bacteriocin production and resistance to drugs are advantageous features for Lactobacillus acidophilus La-14, a potential probiotic strain
JP2012504958A5 (enExample)
Wakai et al. Repressive processing of antihypertensive peptides, Val-Pro-Pro and Ile-Pro-Pro, in Lactobacillus helveticus fermented milk by added peptides
CA2707093A1 (en) Thuricin cd, an antimicrobial for specifically targeting clostridium difficile
JP2017533177A5 (enExample)
CA2711462C (en) Novel antibiotic peptide derived from ribosomal protein l 1 of helicobacter pylori and use thereof
MX2021015563A (es) Polipéptidos anti-microbianos, derivados de bacteriófago, y sus usos contra bacterias gramnegativas y acidorresistentes.
CN115947802A (zh) 一种抗菌物质吉类菌素的制备及重组表达方法和医用用途
CN111356473A (zh) 用于治疗感染的lactoferricin和lactoferrampin
US20190315814A1 (en) Lantibiotic variants and uses thereof
EP3922309A1 (en) Novel lactococcus lactis strain for the production of bioactive compounds having antimicrobial effect
KR102637772B1 (ko) 위건강과 구강질환 관련 미생물 및 병원성 미생물에 대한 항균활성을 갖는 산삼 유래 락토바실러스 플란타럼 wg.q7 균주 및 이의 용도
Oladipo et al. Bioprotective potential of bacteriocinogenic Enterococcus gallinarum strains isolated from some Nigerian fermented foods, and of their bacteriocins
KR20100059668A (ko) Lactococcus lactis NK34 유래의 박테리오신 및 이를 유효성분으로 하는 젖소 유방염 치료제
CN118648631A (zh) 一种海参保鲜剂及用途
WO2023150886A1 (en) Probiotic strain for countering caries pathogens
Munkhtsetseg et al. Isolation of lactic acid bacteria with high biological activity from local fermented dairy products